ProfileGDS4095 / 212390_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 67% 66% 67% 67% 67% 65% 63% 62% 63% 65% 64% 63% 64% 64% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep16.2087167
GSM709769LY2 SRC1-siRNA tamoxifen treated rep35.9139566
GSM709765LY2 SRC1-siRNA untreated rep36.0399867
GSM709771LY2 SRC1-siRNA untreated rep16.1509567
GSM709772LY2 SRC1-siRNA untreated rep26.0892867
GSM709775LY2 SRC1-siRNA untreated rep45.7588765
GSM709764LY2 control-siRNA tamoxifen treated rep25.3423363
GSM709766LY2 control-siRNA tamoxifen treated rep35.0958162
GSM709768LY2 control-siRNA tamoxifen treated rep15.3834663
GSM709777LY2 control-siRNA tamoxifen treated rep45.6954265
GSM709770LY2 control-siRNA untreated rep35.6311264
GSM709773LY2 control-siRNA untreated rep15.4061563
GSM709774LY2 control-siRNA untreated rep25.4674364
GSM709776LY2 control-siRNA untreated rep45.4834964